200 related articles for article (PubMed ID: 38662551)
1. TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.
Li MY; Chong LC; Duns G; Lytle A; Woolcock B; Jiang A; Telenius A; Ben-Neriah S; Nawaz W; Slack GW; Elisia I; Viganò E; Aoki T; Healy S; Krystal G; Venturutti L; Scott DW; Steidl C
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2320421121. PubMed ID: 38662551
[TBL] [Abstract][Full Text] [Related]
2. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.
Pham LV; Fu L; Tamayo AT; Bueso-Ramos C; Drakos E; Vega F; Medeiros LJ; Ford RJ
Blood; 2011 Jan; 117(1):200-10. PubMed ID: 20889926
[TBL] [Abstract][Full Text] [Related]
3. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway.
He JQ; Saha SK; Kang JR; Zarnegar B; Cheng G
J Biol Chem; 2007 Feb; 282(6):3688-94. PubMed ID: 17158868
[TBL] [Abstract][Full Text] [Related]
4. An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression.
Zhang B; Calado DP; Wang Z; Fröhler S; Köchert K; Qian Y; Koralov SB; Schmidt-Supprian M; Sasaki Y; Unitt C; Rodig S; Chen W; Dalla-Favera R; Alt FW; Pasqualucci L; Rajewsky K
Cell Rep; 2015 May; 11(5):715-26. PubMed ID: 25921526
[TBL] [Abstract][Full Text] [Related]
5. The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathways.
Muro I; Fang G; Gardella KA; Mahajan IM; Wright CW
Cell Cycle; 2014; 13(12):1918-27. PubMed ID: 24739416
[TBL] [Abstract][Full Text] [Related]
6. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
[TBL] [Abstract][Full Text] [Related]
7. Activation-induced tumor necrosis factor receptor-associated factor 3 (Traf3) alternative splicing controls the noncanonical nuclear factor κB pathway and chemokine expression in human T cells.
Michel M; Wilhelmi I; Schultz AS; Preussner M; Heyd F
J Biol Chem; 2014 May; 289(19):13651-60. PubMed ID: 24671418
[TBL] [Abstract][Full Text] [Related]
8. Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells.
McPherson AJ; Snell LM; Mak TW; Watts TH
J Biol Chem; 2012 Jun; 287(27):23010-9. PubMed ID: 22570473
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.
Liao G; Zhang M; Harhaj EW; Sun SC
J Biol Chem; 2004 Jun; 279(25):26243-50. PubMed ID: 15084608
[TBL] [Abstract][Full Text] [Related]
10. Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.
Bushell KR; Kim Y; Chan FC; Ben-Neriah S; Jenks A; Alcaide M; Fornika D; Grande BM; Arthur S; Gascoyne RD; Steidl C; Morin RD
Blood; 2015 Feb; 125(6):999-1005. PubMed ID: 25468570
[TBL] [Abstract][Full Text] [Related]
11. Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling.
Takaori-Kondo A; Hori T; Fukunaga K; Morita R; Kawamata S; Uchiyama T
Biochem Biophys Res Commun; 2000 Jun; 272(3):856-63. PubMed ID: 10860842
[TBL] [Abstract][Full Text] [Related]
12. The noncanonical NF-κB pathway.
Sun SC
Immunol Rev; 2012 Mar; 246(1):125-40. PubMed ID: 22435551
[TBL] [Abstract][Full Text] [Related]
13. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.
Zarnegar B; Yamazaki S; He JQ; Cheng G
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3503-8. PubMed ID: 18292232
[TBL] [Abstract][Full Text] [Related]
14. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
Song YJ; Kang MS
Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
[TBL] [Abstract][Full Text] [Related]
15. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
Vallabhapurapu S; Matsuzawa A; Zhang W; Tseng PH; Keats JJ; Wang H; Vignali DA; Bergsagel PL; Karin M
Nat Immunol; 2008 Dec; 9(12):1364-70. PubMed ID: 18997792
[TBL] [Abstract][Full Text] [Related]
16. TNF receptor-related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF-κB-inducing kinase-mediated hepatocyte transdifferentiation.
Shiode Y; Kodama T; Shigeno S; Murai K; Tanaka S; Newberg JY; Kondo J; Kobayashi S; Yamada R; Hikita H; Sakamori R; Suemizu H; Tatsumi T; Eguchi H; Jenkins NA; Copeland NG; Takehara T
Hepatology; 2023 Feb; 77(2):395-410. PubMed ID: 34995376
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C-associated kinase is required for NF-kappaB signaling and survival in diffuse large B-cell lymphoma cells.
Kim SW; Oleksyn DW; Rossi RM; Jordan CT; Sanz I; Chen L; Zhao J
Blood; 2008 Feb; 111(3):1644-53. PubMed ID: 18025152
[TBL] [Abstract][Full Text] [Related]
18. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells.
Sasaki Y; Calado DP; Derudder E; Zhang B; Shimizu Y; Mackay F; Nishikawa S; Rajewsky K; Schmidt-Supprian M
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10883-8. PubMed ID: 18663224
[TBL] [Abstract][Full Text] [Related]
19. Noncanonical NF-κB activation by the oncoprotein Tio occurs through a nonconserved TRAF3-binding motif.
de Jong SJ; Albrecht JC; Giehler F; Kieser A; Sticht H; Biesinger B
Sci Signal; 2013 Apr; 6(272):ra27. PubMed ID: 23612708
[TBL] [Abstract][Full Text] [Related]
20. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling.
Allen IC; Wilson JE; Schneider M; Lich JD; Roberts RA; Arthur JC; Woodford RM; Davis BK; Uronis JM; Herfarth HH; Jobin C; Rogers AB; Ting JP
Immunity; 2012 May; 36(5):742-54. PubMed ID: 22503542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
